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Abstract
Background
We designed a straightforward method for discriminating circulating Leishmania populations
in the Indian subcontinent (ISC). Research on transmission dynamics of visceral leishmania-
sis (VL, or Kala-azar) was recently identified as one of the key research priorities for elimina-
tion of the disease in the ISC. VL in Bangladesh, India, and Nepal is caused by genetically
homogeneous populations of Leishmania donovani parasites, transmitted by female sand-
flies. Classical methods to study diversity of these protozoa in other regions of the world,
such as microsatellite typing, have proven of little use in the area, as they are not able to dis-
criminate most genotypes. Recently, whole genome sequencing (WGS) so far identified 10
different populations termed ISC001-ISC010.
Methodology / Principle findings
As an alternative to WGS for epidemiological or clinical studies, we designed assays based
on PCR amplification followed by dideoxynucleotide sequencing for identification of the non-
recombinant genotypes ISC001 up to ISC007. These assays were applied on 106 parasite
isolates collected in Nepal between 2011 and 2014. Combined with data from WGS on
strains collected in the period 2002–2011, we provide a proof-of-principle for the application
of genotyping to study treatment outcome, and differential geographic distribution.
Conclusions / Significance
Our method can aid in epidemiological follow-up of visceral leishmaniasis in the Indian sub-
continent, a necessity in the frame of the Kala-azar elimination initiative in the region.
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Author summary
Visceral Leishmaniasis (VL) or Kala-azar is a life-threatening neglected tropical disease that
annually affects half a million people worldwide. In the Indian subcontinent (India, Nepal,
Bangladesh), the disease is caused by infection with the protozoan parasite Leishmania dono-
vani, which is transmitted by female sand flies. Currently, the Kala-azar elimination program
aims at reducing the number of VL cases in the region to less than 1 in 10.000 at upazila,
sub-district and district level in Bangladesh, India, and Nepal respectively. In support of this
program, tools for tracking L. donovani populations are essential, because these allow moni-
toring geographic spread over time. However, the parasite populations in the region are
highly homogeneous, requiring sequencing of the entire genome to gather sufficient infor-
mation for discriminating them. Because whole genome sequencing (WGS) is impractical
for large-scale use, we designed a simple alternative to identify the WGS-genotypes. Our
method is based on PCR amplification followed by sequencing of one particular locus, diag-
nostic of each population. We provide proof-of-principle that our method can be used to
track parasite populations over time, and to correlate them with clinical parameters. We
believe that our assay can support the Kala-azar control efforts in the Indian subcontinent.
Introduction
Visceral Leishmaniasis (VL) is a neglected tropical disease caused by parasites of the Leishmania
donovani species complex, which are transmitted by the bite of phlebotomine sand flies. WHO
estimates that annually, 300 million people worldwide are at risk of VL [1]. In the Indian subcon-
tinent (ISC), including Bangladesh, India, and Nepal, each year an estimated 237,500 new cases
occurred, of which 4,450 in Nepal [2]. Together this accounts for 80% of all new VL cases world-
wide. However, recently VL incidence is declining in the Indian subcontinent, and the numbers
of new reported cases have dropped to 735, 9241, and 335 respectively in the aforementioned
countries in 2014 [3]. Monitoring/tracking the genetic diversity of the parasites in these endemic
regions over time is essential to understand transmission dynamics. This can help to evaluate the
effect of both preventive and curative intervention programs, to monitor progress towards elimi-
nation, and to study the dynamics of variants associated with specific phenotypes.
Several molecular assays for identifying populations of L. donovani have been developed.
Among these are sequencing of ribosomal loci [4], multi-locus microsatellite typing [5], multi-
locus sequence typing [6], amplified fragment length polymorphism analysis [7], and kineto-
plast minicircle DNA RFLP (restriction fragment length polymorphism) analysis [8,9]. These
methods are capable of discriminating a number of genotypes, but are less effective in recently
evolving epidemic parasite populations which are relatively homogeneous, such as L. donovani
in the ISC. A phylogenomic study, based on whole genome sequences of over 200 clinical ISC
parasite isolates, allowed documenting genetic diversity on a much finer scale [10]. Based on
single point mutations (SNPs), ten major ISC populations (named ISC001-ISC010) could be
defined. Seven of them (ISC001-ISC007) represented congruent monophyletic groups, while
the remaining three (ISC008-ISC010) contained mixed signatures of these.
Because whole genome sequencing (WGS) cannot currently be applied in all laboratories,
our goal was to develop simpler molecular assays for discriminating ISC001-ISC007 in individ-
ual isolates, based on PCR amplification followed by amplicon sequencing, further called ISC
single locus genotyping (ISC-SLG). This will allow application in epidemiological surveys
and transmission studies. In case of genotype ISC005, such assay could also have a clinical
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relevance, as this genotype was shown to correlate with antimonial drug resistance and treat-
ment failure [10]. After development of the assay and evaluation of its analytical performance,
we applied it to Nepalese isolates that were collected in the years following the WGS survey,
and analyzed the spread of genotypes over time and space.
Methods
Ethics statement
Ethical clearance was obtained from the institutional review boards of the Nepal Health
Research Council, Kathmandu, Nepal and the corresponding body of the Institute of Tropical
Medicine, Antwerp, Belgium.
Sample collection and parasite isolation
The sample collection consisted of a total of 204 Leishmania isolates from 195 confirmed VL
patients who presented between 2002 and July 2014 at the B. P. Koirala Institute of Health Sci-
ences (BPKIHS), a tertiary care medical center in Dharan, Nepal. The clinical criteria were
fever for more than 2 weeks, combined with hepatomegaly and/or splenomegaly. The labora-
tory criteria were a positive rK39 rapid diagnostic test (InBiOS, Cat. nr. INS015) [11,12], and
bone marrow smear positivity. Written informed consent was obtained from patients, or from
parents or guardians in case of children.
Detailed geographical and clinical information of each patient is provided in S1 Database.
Among the 195 patients, 9 were treated twice because they either did not respond to the first
treatment, or relapsed. The period during which the second treatment was administered is
referred to as second episode, hence our study included 204 disease episodes. Of these, treatment
history of 26 was not traceable. The remaining episodes were treated with antimonials (Sodium
stibogluconate, SSG), Miltefosine (MIL), or Amphotericin B (AmB) in 33, 85, and 57 cases,
respectively, while in 3 cases treatment was not completed. Treatment failure was recorded for
42 episodes, meaning that patients either did not respond to treatment (persisting clinical signs
and symptoms of VL, positive bone marrow smear after treatment), or they relapsed after initial
cure (reappearance of disease symptoms and/or positive bone marrow smear during 12 months
follow-up). Of these 42 episodes, SSG was used in 10, MIL in 29, and AmB in 3 cases.
Parasite promastigotes were derived from bone marrow aspirates of VL patients by cultur-
ing in Tobie’s blood agar medium with Locke’s overlay [13], with 200 IU/ml penicillin and
200 μg/ml streptomycin. Once the parasites were fully grown from the clinical material, they
were transferred to M199 (Sigma-Aldrich, cat. nr. 2520) with 20% fetal calf serum (Invitrogen,
cat. nr. 10270). The parasite cultures were grown to late logarithmic growth phase and cryo-
preserved at -80˚C with 10% sterile glycerol.
Parasite DNA extraction and species identification
A total of 204 parasite cultures were isolated at BPKIHS, one for each disease episode. Out of
these, 98 had been previously analyzed by WGS [10], while 106 were genotyped in this study
with ISC-SLG. DNA was extracted from parasite cultures using the QiaAmp DNA mini kit
(Qiagen, www.qiagen.com). Parasites in late logarithmic growth phase were washed thrice
with sterile PBS solution and DNA was eluted in 200 μL AE buffer. DNA concentration and
purity was verified by spectrophotometric measurement with the NanoDrop 2000 (Thermo
Scientific, Waltham, MA, USA). The species of L. donovani was confirmed using PCR-RFLP
analysis of the heat-shock protein 70 gene (hsp70). The fragments referred to as HSP70-N [14]
were digested with restriction enzymes HincII (the isoschizomer of HindII) [15], and MluI.
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Development of ISC-SLG
Previous WGS analysis of L. donovani from ISC identified 10 populations [10], seven of which
(ISC001-ISC007) being characterized by a unique combination of apomorphic homozygous
SNPs or INDELs (insertions/deletions). The remaining three (ISC008-ISC010) represented
composite genotypes. For each of the genotypes ISC001-ISC007, a unique apomorphic homo-
zygous SNP or INDEL was selected for designing a specific assay. PCR primers were chosen to
amplify about 500 nucleotides flanking each SNP/insertion at both sides. The same primers
were used for the amplicon sequencing.
PCR amplification for ISC-SLG
PCR assays were done in 50 μl final reaction volume which contained 1x PCR buffer with a
total of 2 mM MgCl2, 200 μM of each dNTP, 1 μM of each primer, and 1.5 units of HotStarTaq
Plus DNA polymerase (Qiagen, Cat. nr. 203605). Finally, 0.1 to 1 ng of L. donovani DNA was
added. Since SNPs of ISC001 and ISC002 were located in a high GC% locus, 1x Q-solution was
used in both these PCRs to decrease secondary structures. The thermo-cycling program was (i)
initial denaturation at 95˚C for 5 minutes; (ii) 36 cycles of denaturation at 94 ˚C for 1 minute,
annealing at 60˚C for 30 seconds and extension at 72˚C for 45 seconds; and (iii) final extension
at 72˚C for 10 minutes. In addition, two positive controls (1 ng and 0.1 pg parasite DNA of
MHOM/NP/2003/BPK282/0cl4) and two no-template controls were included in each experi-
ment. The amplified PCR-products were verified on a 2% agarose gel prior to sequencing.
The analytical sensitivity was determined for each PCR using reference strain MHOM/NP/
2003/BPK282/0cl4. Ten-fold DNA dilution series in water were examined, ranging from 20 ng
to 0.2 pg added as template. The concentration of the reference DNA was determined using
spectrophotometric measurements with the Nanodrop machine (www.nanodrop.com).
DNA sequence analysis
PCR amplicons were shipped to MACROGEN (www.macrogen.com, Seoul, South Korea) for
capillary sequencing (ABI3730XL DNA Analyzer, Applied Biosystems) with either the forward
or reverse PCR primer. Chromatogram trace files were aligned with the corresponding refer-
ence sequences from WGS data in order to identify the SNPs or insertion in the amplicon.
Because we sequenced only one strand, we ensured having an excellent quality read at the
nucleotide position in question, and no insertions or deletions outside the query area when
aligning to the reference sequence.
Analysis
GPS coordinates of the villages where patients were living were taken from Google maps
(www.google.com.np/maps) [16] and elevations were extracted from the R3.0.3 software
(www.R-project.org) [17] using the “rgbif” package. Bubble plots were made with R3.0.3 using
the “ggplot2” package. GPS plots were generated with QGIS version 2.8.7-Wien (www.qgis.
org) [18] and Google earth (www.google.com/earth) [19].
Results
Assay development
For each of the WGS-defined populations ISC001-ISC004 and ISC006-ISC007, a unique
homozygous SNP was selected: each SNP was thus an apomorphic character for a given popu-
lation, also not found in ISC005 or in any of the composite genotypes ISC008-ISC010. In the
case of ISC005, an apomorphic two-nucleotide insertion (GA) in the Aquaglyceroporin-1 gene
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was selected. Table 1 lists all selected SNPs and INDELs, with their characteristics and chromo-
some location.
The PCR primers that were designed to amplify the specific SNP/INDEL positions with
their flanking regions are given in Table 2. Also indicated are the PCR primer that was used
for sequencing, and the analytical sensitivity as determined on dilution series of parasite DNA.
The analytical sensitivity is illustrated in Fig 1 and ranges between 2 pg and 0.2 pg.
Genotyping of clinical isolates
A total of 204 clinical parasite isolates of L. donovani obtained in Nepal were included in this
study (detailed information in S1 Database), 98 of which were collected between 2002 and
2011 and were previously analyzed with WGS [10]. For the present study, we used ISC-SLG to
classify the remaining 106 isolates collected between mid-2011 and 2014 in genotypes ISC001
(n = 21), ISC003 (n = 9), ISC004 (n = 8), ISC005 (n = 8), ISC006 (n = 16), and ISC007 (n = 0),
Table 1. Genetic markers of ISC-SLG.
Genotype Mutation Type* Chromosome Position@ Gene ID@ Amino Acid change# REFERENCE base˚ SNP/INDEL$
ISC001 Non-syn Ld31 1139549 LdBPK_312340.1 D259G T C
ISC002 Syn Ld31 34009 LdBPK_310140.1 S324 C A
ISC003 Non-syn Ld36 526311 LdBPK_361470.1 H56Y G A
ISC004 Non-syn Ld35 1001055 LdBPK_352450.1 V1343M G A
ISC005 INDEL Ld31 7735 LdBPK_310030.1 Stop - GA
ISC006 NCD Ld33 364481 NA NA A G
ISC007 Non-syn Ld16 130313 LdBPK_160390.1 R77K C T
* Non-syn = Non-synonymous SNP, Syn = Synonymous SNP, NCD = Non-coding, INDEL = Insertion/Deletion.
@ Annotation in database of GeneDB Ldonovani_BPK282A1_v1 (http://www.genedb.org/web-artemis, last accessed Aug 15, 2016), NA = Not applicable.
# Stop = Stop codon, NA = Not applicable.
˚ REFERENCE = isolate MHOM/NP/2003/BPK282/0cl4.
$ SNP = single base change relative to reference, INDEL = Insertion relative to reference.
doi:10.1371/journal.pntd.0005420.t001
Table 2. PCR primers for ISC-SLG.
Genotype Primer Sequence Amplicon size (bp) Sensitivity
ISC001 Ld31_p1139_F2* CGGTGAGGAATCGCGGCATAG 451 0.2 pg
Ld31_p1139_R2 GCAGCGCCTTCTTGACGTGATG
ISC002 Ld31_p3400_F1* TTCAGCTCCGCAAAGGTCGC 357 0.2 pg
Ld31_p3400_R1 CCGCATGAGCATGCCCAGTC
ISC003 Ld36_p5263_F1* TGCGGGGTGAAAGGCATCCTG 402 0.2 pg
Ld36_p5263_R1 CATGCCGGACACTGACCCGT
ISC004 Ld35_p1001_F1* TCCAACCCTCGTGGCGCAAG 404 0.2 pg
Ld35_p1001_R1 ACACCCACACCGTGCGATCC
ISC005 AQP_IND_F1* CGGCTTGTAGTTGACGGCGGGAG 655 2 pg
AQP_IND_R1 CATGGACAAGGAGGACCCGGAAGG
ISC006 Ld33_p3644_F1 CCCGTGCGTGAAGGCGAACATTT 630 2 pg
Ld33_p3644_R1* GTCAGTGTGCAGGGGCGACGG
ISC007 Ld16_p1303_F2 CTCGCTGCCCACCAGACTTTCT 245 0.2 pg
Ld16_p1303_R2* CGGACAATTTCGCTACTGGTGCT
*PCR primer that was used for sequencing.
doi:10.1371/journal.pntd.0005420.t002
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while 44 could not be classified. This was done in a sequential manner, whereby the assays for
the most common Nepalese genotypes were performed first. Isolates that could not be assigned
to a genotype at this stage were further analyzed for less common genotypes, and so on, till all
six assays were used. If an isolate could not be categorized after running the six assays, it was
listed as “unclassified genotype”. Even though we also developed ISC-SLG for ISC002, we did
not test for this genotype as it was so far only reported from Bangladesh [10], and migration
between both countries is restricted by travel visa requirements. Detailed results of the WGS
and ISC-SLG analyses are provided in S1 Database. Of the 204 isolates, 7 originated from
patients who were treated a second time, and that showed the same genotype as found in the
first disease episode. When these 7 are not taken into account, as they do not represent inde-
pendent data points, we found 33 ISC001, 16 ISC003, 33 ISC004, 15 ISC005, 43 ISC006, and 8
ISC009 isolates, while 49 could not be classified (6/93 analyzed with WGS, 43/104 analyzed
with ISC-SLG).
Fig 2 illustrates the distribution of genotypes over the period of sampling. Genotypes
ISC001 and ISC003-ISC006 were present in most sampled years, with some exceptions. But
even when they were not found in a particular year, they reappeared later on, proving that all
of them circulated continuously in the region. For a given year, the most abundant classified
genotype varied: ISC004 in 2002–2003, ISC006 from 2004 to 2012, and ISC001 in 2013–2014.
ISC009 was the rarest genotype and was not identified after 2011 because no ISC-SLG test is
available. ISC007 was not found in any sample.
The distribution of genotypes according to the treatment outcome of patients with three
different drugs (SSG, MIL and AmB) is shown in Fig 3, whereby only episodes where treat-
ment was completed are included. With respect to SSG, treatment failure was observed only in
ISC004-ISC006, but most patients infected with ISC004 and ISC006 were cured. In contrast,
none of the patients infected with ISC005 cured after SSG treatment. For MIL, relapse was
observed for the 6 identified genotypes but never for the unclassified ones. Half of four MIL
Fig 1. Analytical sensitivity of seven PCRs (Table 2), analyzed on agarose gel. Only the relevant part of
the gels is shown. L. donovani strain MHOM/NP/2003/BPK282/0cl4 DNA was used. The DNA amount used
per reaction ranging from 20 ng to 0.2 pg, is indicated on top. The ISC-SLG PCRs are indicated on the left.
doi:10.1371/journal.pntd.0005420.g001
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treated relapsing patients for which genotyping was done at relapse stage, showed the same
genotype before and after relapse. Two of them however did not: BPK519 and BPK676 were
initially infected with ISC003, but at the time of relapse respectively ISC001 and ISC006 were
isolated. The three cases of AmB relapse were associated with ISC004, ISC006, and an unclassi-
fied genotype.
VL patients included in this study were from 15 administrative districts. Fig 4 shows the
presumed geographical origin of typed parasites over time, with the assumption that patients
got infected in their home village. An overview of the numbers per year and per district is
given in S1 Table. Seven patients for which identical genotypes were recovered before and
after relapse were included only once in this analysis. Genotype ISC001 was mostly present in
hill districts such as Bhojpur, Dhankuta, Khotang, Okhaldhunga, Sankhuwasabha, and Udaya-
pur. Other genotypes were unevenly distributed in the lowland area (Terai). The highest num-
ber of different genotypes was found in the three districts Morang, Sunsari and Saptari.
Discussion
Several Leishmania populations have been documented to circulate in the Indian Subcontinent
[10]. Keeping track of their distribution over time is of particular importance for parasite elimi-
nation by control and treatment measures. Indeed, tracking the spread of populations allows
tracing parasite movements from one area to another, assisting in monitoring control efforts. In
addition, parasites from different populations could react differently to treatment, be carried by
different vectors, or differ in response to vaccines should they become available. Identifying L.
donovani populations in the ISC is however challenged by the fact that they are genetically highly
homogeneous: WGS revealed no more than 2418 SNPs in 191 isolates of the core population
[10]. Previously used methods such as microsatellites, which are effective in other areas in the
Fig 2. Year-wise distribution of genotypes. Years of parasite isolation are at the bottom, genotypes were
identified by WGS or ISC-SLG, as indicated. No samples were available from 2005 to 2008, indicated by a
double vertical line. Genotypes are shown on the left. The diameter of bubble plots represents the number
found in each year. When isolates were derived from different disease episodes of the same patient, they are
shown only if the genotypes in these episodes were different, thereby excluding 5/98 and 2/106 isolates
characterized by WGS and ISC-SLG respectively.
doi:10.1371/journal.pntd.0005420.g002
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world, have shown limited value in this region [5]. Data from WGS offered the additional resolu-
tion needed for distinguishing different populations based on single nucleotide polymorphisms
[10]. Although WGS could be used for large-scale epidemiological surveys or clinical studies, it
remains currently too expensive, has limited availability, and requires too much bio-informatics
analysis time. The ISC-SLG method presented in this paper partly solves these limitations, as it
requires only PCR and classic Sanger sequencing methods, which are far easier to perform and
interpret than WGS, at a significantly smaller cost.
As a proof-of-principle, we investigated the geographic spread of different parasite geno-
types over a period of more than 10 years (2002–2014), combining data from WGS and
ISC-SLG of L. donovani in Nepal. Based on these data we could show that particularly ISC001
has a different geographic distribution as compared to the other genotypes, and is present pre-
dominantly in hilly areas. This could be related to a local epidemic, which is corroborated by a
recent outbreak investigation showing that transmission does take place at higher altitudes
[20]. ISC001 is genetically very different from parasites belonging to the main population
endemic in the Terai lowland, and shows different phenotypic features, hence its epidemiolog-
ical follow-up is highly relevant. No obvious pattern could be seen for the other genotypes,
which are found in the Terai (lowland). As this analysis was merely a proof-of-concept, no
firm conclusions should be drawn. The data collection was not set up for such precise moni-
toring, and only confirmed VL cases visiting the BPKIHS medical services were included. In
addition, the sampling should be extended to other countries of the ISC.
An assessment was presented on differential treatment response from the different geno-
types. Apart from ISC005, which systematically did not react to SSG, no obvious patterns were
seen. The treatment failure of ISC005 infected patients does not come as a surprise, because all
Fig 3. Genotype distribution in relation to treatment outcome for all episodes for which treatment was
completed. Outcomes of three drugs (SSG, MIL, AmB) are given at the bottom, genotypes are shown on the
left. Cure: treatment completed, absence of clinical sign and symptoms of VL until six months for SSG and
AmB, and one year for MIL; Death: death of patient during course of treatment; Non-response: persisting
clinical signs and symptoms of VL, and positive bone marrow smear after treatment; Relapse: reappearance
of disease symptoms and/or positive bone marrow smear after initial cure and during a 12 month follow-up. $#
denotes two MIL treated patients who relapsed but presented infection with a different genotype before and
after relapse: $, BPK519; # BPK676, see S1 Database for details. The diameter of bubble plots is proportional
to the number of the genotypes for each treatment outcome.
doi:10.1371/journal.pntd.0005420.g003
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Fig 4. Spatial-temporal distribution of each L. donovani genotype. The sampling districts (South-East Nepal) are shown at the bottom right
panel. BPKIHS (Dharan) is indicated with a red cross. One ISC001 isolate of 2014 originated from the Banke district, which is not shown
because it is located in western Nepal. Data can be viewed interactively from https://microreact.org/project/SNP_Genotypes_Nepal
doi:10.1371/journal.pntd.0005420.g004
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parasites of this population have a defective aquaglyceroporin transporter [21]. This trans-
porter is needed for uptake of trivalent antimonials, which are the active derivatives of penta-
valent antimonial drugs such as SSG. It is exactly the underlying 2-nucleotide insertion
responsible for the inactivating frameshift that was used for identification of ISC005. As for
the other treatments, AmB was effective in all genotypes, and MIL frequently resulted in
relapse, also across genotypes. Regarding the latter, no relapse was seen in unclassified geno-
types, which remains to be elucidated: identification of these samples is needed, as well as a suf-
ficiently powered study.
In two patients, different genotypes were detected at the onset of disease and at relapse
stage after MIL treatment. Several scenarios could explain this. First, the patients might have
been simultaneously infected with 2 different genotypes initially, of which one outgrew the
other during culturing. After treatment, the first detected parasite could have been eliminated,
allowing the other to be isolated at the time of relapse. Alternatively, the patients might have
been re-infected with a different genotype, causing the relapse.
As WGS-based methods can be considered the gold standard for identifying parasite popu-
lations because they use nearly all nuclear sequence information, our study can assess the
power of alternative methods based on single or few genes. A previous report, including 31
strains from our analysis, classified Nepalese genotypes with kinetoplast DNA mini-circles,
microsatellites, cysteine proteinase B, glycoprotein 63, and the hydrophilic surface protein B
[9]. This analysis identified 14 kDNA and 8 nuclear genotypes, which in general correlated
well with WGS-defined genotypes (data provided in S1 Database), even though there was no
perfect one-to-one relationship. This could be explained by the fact that microsatellites tend to
suffer from homoplasy [22], mini-circles are highly variable and difficult to analyze in a repro-
ducible manner, and genetic homogeneity calls for analysis of many loci in parallel.
We applied ISC-SLG on parasite cultures, but so far not on clinical samples. Nevertheless,
the analytical sensitivity of the assays was between 0.2 and 2 pg, or roughly 1 to 10 parasite
genomes, which makes the assay at least theoretically usable on VL samples with sufficient par-
asite load, such as bone marrow aspirates, spleen/liver biopsies, and even blood [23]. In addi-
tion, also tissue from Post-Kala-azar dermal leishmaniasis (PKDL) patients was shown to
surpass this threshold [24]. Also, currently efforts are ongoing to specifically select or amplify
low abundant parasite DNA from clinical samples, which may provide new opportunities to
extract useful genetic information from these [25].
Improvement of ISC-SLG could involve the use of multiplex and real-time PCR. Currently,
each genotype requires a different PCR, and these could be combined in a single tube by multi-
plexing to increase speed and reduce cost. Moreover, as illustrated in this paper, analysis can
be done in a sequential manner, whereby samples are first tested for the most abundant geno-
type(s) instead of running all assays simultaneously. Further, to enhance throughput and com-
patibility with existing infrastructure in low-resource settings, sequencing could be avoided by
using fluorescent real-time PCR probes as shown by Feehery et al. and Tyagi et al. [26,27].
It should be noted that ISC-SLG can detect documented genotypes/populations, but does
not allow identification of new ones or alternative genotypes showing the same polymorphism
as used in the assay. Indeed, 42% of tested parasite isolates could not be classified. These could
either represent hitherto undetected genotypes, or populations for which no ISC-SLG test was
developed or used. Nevertheless, highly useful information can be obtained even by tracking
half of the circulating genotypes, as it can provide insight into the way of spreading, and hint
to invasion of new genotypes in a particular area. Hence, WGS remains complementary to our
method, allowing to investigate new genotypes and serving as a basis for developing additional
ISC-SLG assays.
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In conclusion, ISC-SLG was successfully applied to cultured isolated parasites from various
locations in Nepal. The method needs further improvement, but is already in its current ver-
sion a practical tool for use in clinical studies and epidemiological surveys. As such it contrib-
utes to “research on epidemiology and transmission dynamics of VL”, one of the key research
priorities for visceral leishmaniasis elimination recently suggested by Singh et al. [28]. Apply-
ing our technique in country-wide systematic epidemiological surveys would help to better
understand and control leishmaniasis in Nepal. The method could easily be extended to addi-
tional genotypes circulating in other regions of the ISC, in support of the Kala-azar elimination
program.
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